In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Delays Implementation Of Radiofrequency Identification Standards

This article was originally published in The Pink Sheet Daily

Executive Summary

With many new technologies to combat counterfeiting, agency appears to want more time to get the implementation of quality control legislation right, say some sources.
Advertisement

Related Content

Track and Trace Standards Coming Shortly, FDA Says
FDA Wants Authority To Enforce Track-And-Trace System For Drugs
FDA Wants Authority To Enforce Track-And-Trace System For Drugs
FDA Refining "Track And Trace" Standards For Rx Drugs
FDA Refining "Track And Trace" Standards For Rx Drugs

Topics

Advertisement
UsernamePublicRestriction

Register

PS071657

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel